EXAS Stock Set to Benefit From Favorable Study Data Backing MCED Test
Chairman of The Board & CEO of Exact Sciences Picks Up 2.7% More Stock
Life Sciences Stocks Viewed Positively at TD Cowen Despite Post-election Weakness
Exact Sciences Insider Bought Shares Worth $1,001,325, According to a Recent SEC Filing
Exact Sciences Unveils Data Showing Promise of Multi-Cancer Early Detection at AACR Special Conference on Liquid Biopsy
Exact Sciences CEO Kevin Conroy Buys 19,500 Shares At $51.35 Each, Investing $1M; Now Holds 1.07M Direct Shares, With Total Holdings Reaching 1.41M Shares Plus 683K Options And Restricted Stock Units